mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.03 |
mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.03 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
0.065 |
0.03 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |